ArticleEpigenomics2024
Integrated epigenomic exposure signature discovery.
Abstract read
In one paragraph
Article in Epigenomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Omics and Multiomics-Based Diagnostics for Invasive Candidiasis: Toward Precision Medicine.Molecular & cellular proteomics : MCP · 2025Review
- Altered epigenetic landscape as infectious disease diagnostics.Epigenomics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors.
Jared SchuetterHealth Business Unit, Battelle Memorial Institute, Columbus, OH 43201, USA.
Angela Minard-SmithHealth Business Unit, Battelle Memorial Institute, Columbus, OH 43201, USA.
Brandon HillNationwide Insurance, Columbus, OH 43215, USA.
Jennifer L BeareHealth Business Unit, Battelle Memorial Institute, Columbus, OH 43201, USA.
Alexandria VornholtIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Thomas W BurkeDivision of Infectious Diseases, Duke University, Durham, NC 27710, USA.
Vel MuruganCenter for Personalized Diagnostics, Biodesign Institute at Arizona State University, Tempe, AZ 85281, 85281USA.ORCID 0000-0002-7368-7742
Anthony K SmithHealth Business Unit, Battelle Memorial Institute, Columbus, OH 43201, USA.
Thiruppavai ChandrasekaranCenter for Personalized Diagnostics, Biodesign Institute at Arizona State University, Tempe, AZ 85281, 85281USA.
Hiba J ShammaHealth Business Unit, Battelle Memorial Institute, Columbus, OH 43201, USA.
Sarah C KahaianHealth Business Unit, Battelle Memorial Institute, Columbus, OH 43201, USA.
Keegan L FillingerHealth Business Unit, Battelle Memorial Institute, Columbus, OH 43201, USA.
Mary Anne S AmperIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Wan-Sze ChengIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Yongchao GeIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Mary Catherine GeorgeIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Kristy GuevaraIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Nora Lovette-OkwaraIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Avinash MahajanIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Nada MarjanovicIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Natalia MendelevIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Vance G FowlerDivision of Infectious Diseases, Duke University, Durham, NC 27710, USA.
Micah T McClainDivision of Infectious Diseases, Duke University, Durham, NC 27710, USA.
Clare M MillerIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Sagie MofsowitzIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Venugopalan D NairIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
German NudelmanIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Thomas G EvansBarinthus Biotherapeutics, Harwell, Oxfordshire, UK.
Flora CastellinoBiomedical Advanced Research & Development Authority-Administration for Strategic Preparedness & Response,Washington, DC 20201, USA.
Irene RamosIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Stas RirakIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Frederique Ruf-ZamojskiIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Nitish SeenarineIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Alessandra Soares-ShanoskiIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Sindhu VangetiIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Mital VasoyaIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Xuechen YuIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Elena ZaslavskyIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Lishomwa C NdhlovuDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
Michael J CorleyDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
Scott BowlerDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
Steven G DeeksUniversity of California San Francisco, San Francisco, CA 94143, 94143USA.
Andrew G LetiziaNaval Medical Research Unit INDO PACIFIC, Singapore.
Stuart C SealfonIcahn School of Medicine at Mount Sinai, New York City, NY 10029, 10029USA.
Christopher W WoodsDivision of Infectious Diseases, Duke University, Durham, NC 27710, USA.
Rachel R SpurbeckHealth Business Unit, Battelle Memorial Institute, Columbus, OH 43201, USA.
Funding
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIVR01MH134391 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI Michael Jay Corley, Shelli Farhadian · 2023 to 2026
$3.8MDefense Advanced Research Programs Agency Biological Technology Office W911NF19C0041Defense Health Agency 9700140NIMH NIH HHS R01 MH134391
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19EpigenomicsMachine LearningStaphylococcus aureusAlgorithmsBacillus anthracisEpigenesis, GeneticEpigenomeHIV InfectionsHumansInfluenza A Virus, H3N2 SubtypeInfluenza, HumanSARS-CoV-2Transcriptomediagnosticsepigenomicsexposure healthinfectionmachine learningmulti-omicstranscriptomics
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.